Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biol Macromol ; 267(Pt 1): 131388, 2024 May.
Article in English | MEDLINE | ID: mdl-38608982

ABSTRACT

We developed a facile method for the fabrication of a biodegradable delivery system composed of two blocks: curdlan and curcumin. This was achieved by chemical functionalization of curdlan through tosylation, amination followed by complexation with curcumin. A comprehensive evaluation of structural characterization and component stability showed that cur-cum complex exhibited better anticancer properties with enhanced thermal properties. The cur-cum complex shows pH sensitive sustained release behaviour with higher release at acidic pH and kinetic data of drug release follows the Korsmeyer-Peppas model. The cur-cum complex has ability to block the proliferation of the MCF-7 cell line as revealed by MTT assay which showed increased toxicity of cur-cum complex against these cell lines. The results obtained from western blot analysis demonstrated that the co-administration of cur and cum effectively induced apoptosis in MCF-7 cells. This effect was observed by a considerable upregulation of the Bcl-2/Bax ratio, a decline in mRNA expression of LDHA, level of lactate and LDH activity. The results clearly depict the role of functionalized curdlan as efficient carrier for curcumin delivery with prolonged, sustained release and enhanced bioavailability, thereby improving the overall anticancer activity.


Subject(s)
Apoptosis , Breast Neoplasms , Curcumin , Drug Liberation , beta-Glucans , Curcumin/pharmacology , Curcumin/chemistry , Curcumin/administration & dosage , beta-Glucans/chemistry , beta-Glucans/pharmacology , Humans , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Breast Neoplasms/metabolism , MCF-7 Cells , Female , Apoptosis/drug effects , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Drug Carriers/chemistry , Drug Delivery Systems , Cell Proliferation/drug effects , Hydrogen-Ion Concentration
2.
Int J Biol Macromol ; 183: 1495-1504, 2021 Jul 31.
Article in English | MEDLINE | ID: mdl-34029580

ABSTRACT

Guar gum is a neutral, non-ionic polysaccharide that has been extensively utilized in the food industry as a stabilizer, excipients, and emulsifier agent. An oxidized derivative of this edible guar gum was prepared and used as a complexing agent for iron to obtain a polysaccharide-bound iron (II) complex. The degree of oxidation varies between 30.12 and 60.63% with a corresponding aldehyde content (0.59-1.79 mmol/g) and carboxyl contents (0.49-1.62 mmol/g), which were determined by the titrimetry method. Sophisticated spectroscopic techniques characterized all the products. The natural polymer-based hydrophilic and hydrophobic formulations as coating were used for achieving the sustained or prolonged release from the complex tablets. Release studies of the tablets were carried out in different mediums of varying pH. The total iron available from the tablets was compared with that obtained from ferrous fumarate prepared under similar conditions, and the results were found to be comparable. Release results demonstrate the pH-sensitive behaviour of the guar gum-based delivery system towards the controlled release of iron. Antianemic effect of new functionalized guar gum iron complexes was investigated on male albino rats. The complexes may exhibit the potential to recover the hematological index of the albino rats with some positive effects on improving rat's growth with iron deficiency anaemia.


Subject(s)
Anemia/drug therapy , Galactans/chemistry , Iron/chemistry , Mannans/chemistry , Plant Gums/chemistry , Anemia, Iron-Deficiency/drug therapy , Animals , Hydrogen-Ion Concentration , Hydrophobic and Hydrophilic Interactions , Male , Rats , Solubility , Tablets/chemistry , Tablets/therapeutic use
3.
J Biochem Mol Toxicol ; 35(1): e22625, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32894639

ABSTRACT

Hepatocellular carcinoma (HCC) is the fifth most commonly diagnosed cancer worldwide and is associated with poor prognosis. The current study aimed to assess the therapeutic efficacy of resveratrol when administered alone and in combination with nicotinamide against alcohol-aflatoxin B1-induced HCC. Results reveal that during the development and progression of cancer, there was a decline in the level of antioxidant enzymes catalase, glutathione peroxidase, glutathione reductase (GR), antioxidant glutathione, and glutathione S-transferase, which is an enzyme of detoxification pathways. Treatment of resveratrol restored the level of catalase and glutathione peroxidase toward normal in alcohol-aflatoxin B1-induced HCC; however, nicotinamide worked in concert with resveratrol only in upregulating the activity of glutathione reductase, glutathione level, and glutathione S-transferase. SIRT1 agonist resveratrol was observed to modulate the activity of antioxidant enzymes by negatively regulating the expression of nuclear factor-κB (NF-κB) in alcohol-aflatoxin B1-induced HCC, thereby suggesting a cross-talk between antioxidant enzymes SIRT1 and NF-κB during the development and progression of HCC and its therapeutics by resveratrol and nicotinamide.


Subject(s)
Aflatoxin B1/toxicity , Antioxidants/metabolism , Carcinoma, Hepatocellular/metabolism , Ethanol/toxicity , Liver Neoplasms, Experimental/metabolism , NF-kappa B/genetics , Neoplasm Proteins/metabolism , Niacinamide/pharmacology , Resveratrol/pharmacology , Sirtuin 1/metabolism , Animals , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/pathology , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/pathology , Male , Rats
4.
J Biochem Mol Toxicol ; 34(11): e22576, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32640115

ABSTRACT

Hepatocellular carcinoma (HCC) is a type of primary liver cancer and dietary exposure to aflatoxins is a major risk factor of HCC. The current study aimed to assess the role of resveratrol and nicotinamide in renal toxicity during alcohol-aflatoxin-B1-induced HCC. The results revealed that resveratrol treatment normalized the level of urea, lipid peroxidation, lactate and lactate dehydrogenase, which were increased in HCC. It also downregulated the increased expression of sirtuin 1 in HCC kidney. Furthermore, amelioration of oxidative stress in kidney of HCC rats by resveratrol was observed to be catalase dependent and glutathione peroxidase independent.


Subject(s)
Aflatoxin B1/toxicity , Catalase/metabolism , Ethanol/toxicity , Glutathione Peroxidase/metabolism , Kidney/drug effects , Liver Neoplasms, Experimental/chemically induced , Oxidative Stress/physiology , Resveratrol/pharmacology , Animals , Kidney/metabolism , Male , Rats, Wistar , Sirtuin 1/physiology
5.
Front Biosci (Landmark Ed) ; 24(2): 366-381, 2019 01 01.
Article in English | MEDLINE | ID: mdl-30468661

ABSTRACT

Global metabolism of cancers exhibits a peculiar phenotype that is lactate acidosis (high lactate with acidic pH) in tumor microenvironment. Why tumor microenvironment becomes so responsive towards lactate is still not clear. In this review we have discussed lactate generation and recycling either exogenously, directly or indirectly by cancer cells via some transporters. Tumor cells in hypoxia use glucose rapidly and produce lactate while cells which have profuse oxygen supply take up lactate and use it for energy production which is referred as lactate shuttling between tumor cells. Escaping immune evasion which is also an emerging hallmark of cancer cells has also been discussed in this review with respect of lactate acidosis.


Subject(s)
Glycolysis , Lactic Acid/metabolism , Neoplasms/metabolism , Signal Transduction , Cell Hypoxia , Cell Line, Tumor , Cell Survival , Humans , Hydrogen-Ion Concentration , Hypoxia , Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...